MECP2 and acute myeloid leukemia: ROC analyses confirmed the strong discriminatory power of MELTF, CRK, GSPT1, KPNA1, and MECP2 in distinguishing AML from healthy controls, underscoring their role as key biomarkers for AML susceptibility, especially in workers exposed to benzene.